Logo image of ZYXI

ZYNEX INC (ZYXI) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:ZYXI - US98986M1036 - Common Stock

0.125 USD
-0.07 (-34.9%)
Last: 12/23/2025, 8:00:03 PM
0.13 USD
+0.01 (+4%)
After Hours: 12/23/2025, 8:00:03 PM

ZYXI Key Statistics, Chart & Performance

Key Statistics
Market Cap3.80M
Revenue(TTM)108.20M
Net Income(TTM)-73.96M
Shares30.39M
Float15.75M
52 Week High8.45
52 Week Low0.12
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-1.41
PEN/A
Fwd PEN/A
Earnings (Next)03-09
IPO2002-11-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
ZYXI short term performance overview.The bars show the price performance of ZYXI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

ZYXI long term performance overview.The bars show the price performance of ZYXI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ZYXI is 0.125 USD. In the past month the price decreased by -82.88%. In the past year, price decreased by -98.48%.

ZYNEX INC / ZYXI Daily stock chart

ZYXI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ZYXI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ZYXI. ZYXI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZYXI Financial Highlights

Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -540.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -163.18%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-671.43%
Sales Q2Q%-73.26%
EPS 1Y (TTM)-540.63%
Revenue 1Y (TTM)-44.13%

ZYXI Forecast & Estimates

8 analysts have analysed ZYXI and the average price target is 2.91 USD. This implies a price increase of 2225.6% is expected in the next year compared to the current price of 0.125.

For the next year, analysts expect an EPS growth of -1584.67% and a revenue growth -52.33% for ZYXI


Analysts
Analysts82.5
Price Target2.91 (2228%)
EPS Next Y-1584.67%
Revenue Next Year-52.33%

ZYXI Ownership

Ownership
Inst Owners13.71%
Ins Owners47.94%
Short Float %22.98%
Short Ratio0.5

ZYXI Latest News, Press Relases and Analysis

ZYXI Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.72 214.47B
ISRG INTUITIVE SURGICAL INC 63 192.28B
BSX BOSTON SCIENTIFIC CORP 30.5 133.37B
SYK STRYKER CORP 27.59 138.94B
BDX BECTON DICKINSON AND CO 14.46 59.52B
IDXX IDEXX LABORATORIES INC 56.45 56.84B
EW EDWARDS LIFESCIENCES CORP 32.81 48.94B
GEHC GE HEALTHCARE TECHNOLOGY 18.06 37.76B
RMD RESMED INC 26.37 38.11B
DXCM DEXCOM INC 37.28 27.05B
PODD INSULET CORP 62.58 20.12B
ZBH ZIMMER BIOMET HOLDINGS INC 10.97 17.59B

Related stock screener links

About ZYXI

Company Profile

ZYXI logo image Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Company Info

ZYNEX INC

9655 Maroon Circle

Englewood COLORADO 80112 US

CEO: Thomas Sandgaard

Employees: 1000

ZYXI Company Website

ZYXI Investor Relations

Phone: 18004956670

ZYNEX INC / ZYXI FAQ

What does ZYNEX INC do?

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.


What is the current price of ZYXI stock?

The current stock price of ZYXI is 0.125 USD. The price decreased by -34.9% in the last trading session.


Does ZYXI stock pay dividends?

ZYXI does not pay a dividend.


How is the ChartMill rating for ZYNEX INC?

ZYXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is ZYNEX INC (ZYXI) stock traded?

ZYXI stock is listed on the Nasdaq exchange.


When is the next dividend date for ZYNEX INC (ZYXI)?

The next ex-dividend date for ZYNEX INC (ZYXI) is January 5, 2022.


What is ZYNEX INC worth?

ZYNEX INC (ZYXI) has a market capitalization of 3.80M USD. This makes ZYXI a Nano Cap stock.